NICE scraps 7.0% HbA1C targetThe article reports on the need to increase the QOF HbA1a target of patients with type 2 diabetes from 7.0% to 7.5% by the National Institute for Clinical Excellence (NICE), according to the QOF indicator advis...
Mean HbA1c values increased from baseline by 0.2 (plozasiran 50 mg) or 0.3 (plozasiran 25 mg) units overall, with more changes noted in patients with preexisting diabetes or prediabetes. No increases in liver transaminases more than 3 times the upper limit of normal were seen (Table 5)...
The article reports on the move of the National Institute for Clinical Excellence (NICE) in Great Britain to revise the quality and outcomes framework (QOF) indicators for type 2 diab...